Nancy Katz

Nancy Katz is a distinguished, award-winning senior executive with over three decades of robust commercial experience across multi-billion dollar corporations and a track record of success in entrepreneurial healthcare start-ups.

She has held esteemed positions such as CEO, President, and COO, demonstrating her expertise in steering businesses with revenues ranging from $60 million to $1.5 billion.

With a strong foothold in the industry, Nancy has served on the boards of various public and private companies, imparting her knowledge and leadership. Currently, she holds positions on the boards of NURO and CYAN.

Her vast board-level experience includes serving on audit committees for companies like Neutometrix and Neoprobe, as well as contributing to organizations like Planned Parenthood Golden State, LXN, Calypte, and Pepgen.

Nancy's professional focus lies within the healthcare sector, where she excels in areas such as consumer OTC products, medical devices, wearables, life science, and pharmaceuticals.

A visionary leader, Nancy is adept at spearheading companies through transformative periods, leveraging her expertise in sales, marketing, communication, turnarounds, product innovation, compliance, and strategic business expansion.

Her passion for team building is evident in her commitment to fostering growth and rebranding efforts geared towards consumer-focused business strategies across diverse environments.

Nancy Katz is a prominent advocate for women in business, celebrated for her hands-on approach to team and brand building, and is an Adjunct Professor at Brandeis University.